The value of dynamic FDG PET/CT in the differential diagnosis of lung cancer and predicting EGFR mutations.

doi:10.1186/s12890-024-02997-9

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

The value of dynamic FDG PET/CT in the differential diagnosis of lung cancer and predicting EGFR mutations.

BMC pulmonary medicine - 10 May 2024

Wumener Xieraili, Zhang Yarong, Zang Zihan, Du Fen, Ye Xiaoxing, Zhang Maoqun, Liu Ming, Zhao Jiuhui, Sun Tao, Liang Ying

Abstract excerpt

OBJECTIVES: 18F-fluorodeoxyglucose (FDG) PET/CT has been widely used for the differential diagnosis of cancer. Semi-quantitative standardized uptake value (SUV) is known to be affected by multiple factors and may make it difficult to differentiate between benign and malignant lesions. It is crucial to find reliable quantitative metabolic parameters to further support the diagnosis. This study aims to evaluate the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Carcinoma, Squamous Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diagnosis, Differential

Share to ErbB Receptors

Share to Fluorodeoxyglucose F18

Share to Positron Emission Tomography Computed Tomography

Share to Radiopharmaceuticals

Share to ROC Curve

Source

Open in PubMed Open full text

Identifiers

PMID: 38730287
DOI: 10.1186/s12890-024-02997-9
PMCID: PMC11088023

Provenance

PubMed metadata and Literature Corpus relationships.